Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Infection
Published in: Infection 5/2013

01-10-2013 | Correspondence

Presence of Epstein–Barr virus in cerebrospinal fluid from patients with aseptic meningitis appears to be common

Authors: T. Kimiya, T. Yagihashi, M. Shinjoh, A. Kai, Y. Sato

Published in: Infection | Issue 5/2013

Login to get access

Excerpt

To the Editor, …
Literature
1.
Benjamin LA, Kelly M, Cohen D, et al. Detection of herpes viruses in the cerebrospinal fluid of adults with suspected viral meningitis in Malawi. Infection. 2012 Jul 14. [Epub ahead of print].
2.
Kupila L, Vuorinen T, Vainionpäā R, Marttila RJ, Kotilainen P. Diagnosis of enteroviral meningitis by use of polymerase chain reaction of cerebrospinal fluid, stool, and serum specimens. Clin Infect Dis. 2005;40:982–7.PubMedCrossRef
3.
Kelly MJ, Benjamin LA, Cartwright K, et al. Epstein–Barr virus coinfection in cerebrospinal fluid is associated with increased mortality in Malawian adults with bacterial meningitis. J Infect Dis. 2012;205:106–10.PubMedCrossRef
4.
Weinberg A, Bloch KC, Li S, Tang YW, Palmer M, Tyler KL. Dual infections of the central nervous system with Epstein–Barr virus. J Infect Dis. 2005;191:234–7.PubMedCrossRef
Metadata
Title
Presence of Epstein–Barr virus in cerebrospinal fluid from patients with aseptic meningitis appears to be common
Authors
T. Kimiya
T. Yagihashi
M. Shinjoh
A. Kai
Y. Sato
Publication date
01-10-2013
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 5/2013
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-013-0420-4

Other articles of this Issue 5/2013

Infection 5/2013 Go to the issue

Images in Infection

Triple worm infestation in an HIV-infected patient

Clinical and Epidemiological Study

Toxicity and adherence to treatment for latent tuberculosis infection in patients with hematologic malignancies

Correspondence

Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies

Brief Report

High rates of quinolone-resistant strains of Shigella sonnei in HIV-infected MSM

Clinical and Epidemiological Study

Bacterial infection in elderly nursing home and community-based patients: a prospective cohort study

Correspondence

Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits